BIOPHYTIS (EPA:ALBPS) - Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Transparency directive : regulatory news
11/07/2024 07:01
source : webdisclosure.com
BIOPHYTIS's latest news
02/12/2024 07:00
30/09/2024 23:00
30/09/2024 23:00
22/07/2024 08:12
22/07/2024 07:00
11/07/2024 08:13
11/07/2024 07:01
01/07/2024 07:00
01/07/2024 07:00
25/06/2024 23:00
Other stories
21/12/2024 08:21
21/12/2024 06:54
20/12/2024 19:34
21/12/2024 10:26
20/12/2024 18:31
21/12/2024 02:53
21/12/2024 10:53
21/12/2024 02:43
21/12/2024 00:44
21/12/2024 10:24
20/12/2024 17:47
20/12/2024 18:14
21/12/2024 11:39
21/12/2024 03:46
21/12/2024 06:05
Google’s counteroffer to the government trying to break it up is unbundling Android apps - The Verge
21/12/2024 03:03
20/12/2024 19:39
20/12/2024 07:48
21/12/2024 09:57
19/12/2024 14:08
21/12/2024 09:00
21/12/2024 11:00
21/12/2024 08:30
21/12/2024 06:18
20/12/2024 19:59
20/12/2024 16:50
21/12/2024 10:50
21/12/2024 12:18
21/12/2024 10:41
England World Cup winner George Eastham – who changed football forever – dies aged 88... - talkSPORT
20/12/2024 19:31
21/12/2024 10:18
20/12/2024 16:59
20/12/2024 18:55
20/12/2024 11:49
20/12/2024 14:19
21/12/2024 11:00
20/12/2024 21:45
20/12/2024 13:00